AbstractDrug induced complication are becoming increasingly common in CF. In this review we discuss some of the key issues relating to drug side in an ageing population of patients with CF. Strategies to reduce drug complications are also discussed
Over a relatively short period, cystic fibrosis (CF) has gone from a disease of dying children to on...
AbstractBackgroundAzithromycin is widely used as an immunomodulatory agent in the treatment of cysti...
AbstractPatients with cystic fibrosis can develop multi-resistant organisms and may have poor intrav...
Drug induced complication are becoming increasingly common in CF. In this review we discuss some of ...
AbstractCystic fibrosis (CF) is a common autosomal recessive disorder in Caucasian populations with ...
PURPOSE OF REVIEW: Due to continuous development of new drugs and better treatment strategies, survi...
AbstractKidney disease is becoming increasingly common in CF. This review looks at the effect of CFT...
The first regulatory approval for a drug developed specifically for cystic fibrosis (CF) occurred in...
This review seeks to re-introduce cystic fibrosis (CF) clinicians to the pharmacology of drug-drug i...
Background and objective: Intravenous (i.v.) antibiotics are needed for rescue when preventative the...
Clinical presentation of the chronic, heritable condition cystic fibrosis (CF) is complex, with a di...
Background Progressive lung damage from recurrent exacerbations is the major cause of mortality a...
Cystic fibrosis (CF) is one of the commonest life-limiting genetic disorders in the Caucasian popula...
Aims Cystic Fibrosis (CF) is a rare, chronic, progressive, multi-organ disease. It needs life-long,...
AbstractAcute renal insufficiency is known to occur in patients who are taking ciprofloxacin, partic...
Over a relatively short period, cystic fibrosis (CF) has gone from a disease of dying children to on...
AbstractBackgroundAzithromycin is widely used as an immunomodulatory agent in the treatment of cysti...
AbstractPatients with cystic fibrosis can develop multi-resistant organisms and may have poor intrav...
Drug induced complication are becoming increasingly common in CF. In this review we discuss some of ...
AbstractCystic fibrosis (CF) is a common autosomal recessive disorder in Caucasian populations with ...
PURPOSE OF REVIEW: Due to continuous development of new drugs and better treatment strategies, survi...
AbstractKidney disease is becoming increasingly common in CF. This review looks at the effect of CFT...
The first regulatory approval for a drug developed specifically for cystic fibrosis (CF) occurred in...
This review seeks to re-introduce cystic fibrosis (CF) clinicians to the pharmacology of drug-drug i...
Background and objective: Intravenous (i.v.) antibiotics are needed for rescue when preventative the...
Clinical presentation of the chronic, heritable condition cystic fibrosis (CF) is complex, with a di...
Background Progressive lung damage from recurrent exacerbations is the major cause of mortality a...
Cystic fibrosis (CF) is one of the commonest life-limiting genetic disorders in the Caucasian popula...
Aims Cystic Fibrosis (CF) is a rare, chronic, progressive, multi-organ disease. It needs life-long,...
AbstractAcute renal insufficiency is known to occur in patients who are taking ciprofloxacin, partic...
Over a relatively short period, cystic fibrosis (CF) has gone from a disease of dying children to on...
AbstractBackgroundAzithromycin is widely used as an immunomodulatory agent in the treatment of cysti...
AbstractPatients with cystic fibrosis can develop multi-resistant organisms and may have poor intrav...
DOI
Add to ORKG